S100A4 and rheumatoid arthritis: This is exemplified in Senolt et al.,23 where increases in matrix metalloproteinase 1, 2 and 9 protein and gene expression levels were seen in response to S100A4 oligomer treatment of synovial fibroblasts derived from patients with rheumatoid arthritis.